Advocacy intelligence hub — real-time data for patient organizations
University of Pennsylvania — PHASE2
Peking University People's Hospital — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Zhanguo Li
Peking University Institute of Rheuamotology and Immunology
Samuel K Shinjo, PhD
Universidade de Sao Paulo - Rheumatology Division
Shubhasree Banerjee, MD, MD
University of Pennsylvania
📍 PHILADELPHIA, PA
Peter Merkel, MD, MPH, MD, MPH
University of Pennsylvania
📍 RADNOR, PA
Li Zhanguo
Peking University Institute of Rheuamotology and Immunology
Johannes Roth, MD
Children's Hospital of Eastern Ontario